CHATSWORTH, Calif.--(BUSINESS WIRE)--July 24, 2006--North American Scientific, Inc. (Nasdaq:NASI - News) announced today that its NOMOS® Radiation Oncology division has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market nomosSTAT(TM), its new serial tomotherapy automated treatment solution which was introduced at the 47th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in October 2005.
